Tell your friends about this item:
To Compare the Efficacy and Safety of Eplerenone and Spironolactone: in Acute Mi Patients Indermeet Singh Anand
Price
€ 49.99
Ordered from remote warehouse
Expected delivery Nov 19 - 27
Christmas presents can be returned until 31 January
Get notified about new Indermeet Singh Anand releases
Our customers say:
Add to your iMusic wish list
To Compare the Efficacy and Safety of Eplerenone and Spironolactone: in Acute Mi Patients
Indermeet Singh Anand
Aldosterone plays an important role in the pathophysiology of Heart Failure. ACEIs reduces the aldosterone level but it again reach to pre-treatment level after 3-6 months of therapy. The studies like EPHESUS and RALES showed the effectiveness of Eplerenone and Spironolactone in patients having clinical evidence of heart failure after recent Myocardial Infarction. But no direct comparative study between Eplerenone and Spironolactone has been undertaken to show beneficial effect of aldosterone blocker in post MI patient. The current book shows the direct comparative study between Eplerenone and Spironolactone in acute MI patients.
| Media | Books Paperback Book (Book with soft cover and glued back) |
| Released | February 20, 2014 |
| ISBN13 | 9783848444854 |
| Publishers | LAP LAMBERT Academic Publishing |
| Pages | 152 |
| Dimensions | 152 × 229 × 9 mm · 244 g |
| Language | German |